(123 days)
None
No
The description focuses on signal processing and conversion of electrical signals into curves, with no mention of AI or ML algorithms for interpretation or analysis.
Yes
The device measures physiological parameters (FHR, UA, MHR) to provide diagnostic information for monitoring during labor, which is a therapeutic purpose.
No
The device measures physiological signals (fetal heart rate, uterine activity, maternal heart rate) for monitoring purposes, but it does not provide a diagnosis. It is intended to interface with existing perinatal monitors.
No
The device description explicitly states that the LaborView LV1000 is comprised of hardware components including an electrode array, a wireless front-end, a computational back-end, a power supply module, and optional adapters. It also mentions hardware and firmware necessary for signal conversion.
Based on the provided information, the LaborView LV1000™ Wireless Electrode System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the examination of specimens derived from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, prevention, or treatment of a disease or condition.
- LaborView's Function: The LaborView LV1000 is a non-invasive device that measures physiological signals (electrical characteristics of the skin due to muscle contractions, maternal, and fetal ECG) directly from the maternal abdomen using surface electrodes. It does not analyze specimens derived from the body.
- Intended Use: The intended use is to measure fetal heart rate, uterine activity, and maternal heart rate during labor, which are physiological measurements, not diagnostic tests performed on specimens.
Therefore, the LaborView LV1000 falls under the category of a medical device that performs physiological monitoring, rather than an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The LaborView LV1000™ Wireless Electrode System is a transabdominal electromyography and electrocardiography intrapartum maternal-fetal sensor. It works non-invasively via surface electrodes on the maternal abdomen with appropriate monitors to measure fetal heart rate (FHR), uterine activity (UA), and maternal heart rate (MHR). It is indicated for use on women who are at >36 completed weeks, in labor, with singleton pregnancies. It is intended for use by a healthcare professional in a clinical setting.
Product codes
OSP, HGM
Device Description
The LaborView LV1000 is a uterine activity and maternal and fetal heart rate sensor replacement intended to interface to existing perinatal monitors in use in hospital delivery environments.
LaborView is comprised of an electrode array, a wireless front-end ("Front-end"), computational back-end ("Back-end"), a power supply module, and optional adapters to connect to various perinatal monitors. The electrode array is sensitive to changes in electrical characteristics of the skin due to muscle contractions, maternal, and fetal ECG when placed on the expectant mother's abdomen. These signals are passed to LaborView, converted to a contraction curve and maternal heart rate (MHR), and fetal heart rate (FHR), and subsequently passed to the perinatal monitor. Note not all perinatal monitors support input of the MHR.
Labor View includes the hardware and firmware necessary to convert the electrical signals obtained via the electrode array into contraction, MHR, and FHR curves.
Labor View provides analog interfaces to the electrode array and the perinatal monitor but may also interface via USB to a data collection application running on a host PC.
The Front-end mates to the electrode array, digitizes the signals and transmits the signals wirelessly to the Back-end component. The Back-end receives the signals from the Front-end. implements the digital signal processing to create the MHR, FHR and contraction curves, then transmits them via the monitor cable/interface to the existing perinatal monitor.
A variety of connector adapters may exist between the Back-end and the perinatal monitor such that a single Back-end design can interface to a variety of perinatal monitor manufacturers and models.
The LaborView system power is supplied via an isolated power supply or a rechargeable battery pack.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
transabdominal (on the maternal abdomen)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
healthcare professional in a clinical setting.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Usability Study:
- Study Type: Summative usability study.
- Sample Size: Not specified beyond "potential users".
- Key Results: All participants were able to complete all tasks successfully, including sensor array placement, device feedback interpretation, and sensor array removal.
Comparative Clinical Testing (Measurement of Uterine Activity):
- Study Type: Prospective, non-randomized multi-center study.
- Sample Size: Total enrollment was 107 subjects.
- Data Source: Intrapartum patients at term gestation in whom an intrauterine pressure catheter (IUPC) had been placed.
- Comparison: LaborView was compared to standard external sensors [tocodynamometer (Toco) for UA] relative to the gold standard internal sensors [IUPC].
- Key Results: The results of the study indicated that the Labor View device performed as well as Toco for measuring uterine activity.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
For interpretability: a positive percent agreement (PPA) was calculated for each patient. LaborView (or Toco) uterine activity vs. IUPC gold standard was organized into a 2x2 table representing interpretable and uninterpretable data. PPA was defined as the percent of 0.125 second epochs with interpretable IUPC (gold standard data) that are also interpretable by the LaborView or Toco.
For sensitivity: the individual contractions identified by LaborView or toco and the IUPC gold standard vs. those detected only by the IUPC was tabulated. The proportion of contractions detected within +/- 30 seconds by Labor View or Toco was calculated.
For timing accuracy: the difference in timing of corresponding contractions between the IUPC gold standard and the LaborView (or Toco) was calculated.
Predicate Device(s)
K112390 - Monica Healthcare - AN24
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.2720 External uterine contraction monitor and accessories.
(a)
Identification. An external uterine contraction monitor (i.e., the tokodynamometer) is a device used to monitor the progress of labor. It measures the duration, frequency, and relative pressure of uterine contractions with a transducer strapped to the maternal abdomen. This generic type of device may include an external pressure transducer, support straps, and other patient and equipment supports.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of a human figure, with three faces in profile. The figure is stylized and appears to be in motion.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 16, 2015
OBMedical Company % Paul Dryden Regulatory Consultant ProMedic, Inc. 107 SW 140th Terrace, Suite 1 Newberry, FL 32669
Re: K142583
Trade/Device Name: LaborView LV1000 Regulation Number: 21 CFR 884.2720 Regulation Name: External uterine contraction monitor and accessories Regulatory Class: Class II Product Codes: OSP, HGM Dated: December 17, 2014 Received: December 18, 2014
Dear Paul Dryden,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Benjamin R. Fisher -A
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name
LaborView LV1000 Indications for Use (Describe)
The LaborView LV1000™ Wireless Electrode System is a transabdominal electromyography and electrocardiography intrapartum maternal-fetal sensor. It works non-invasively via surface electrodes on the maternal abdomen with appropriate monitors to measure fetal heart rate (FHR), uterine activity (UA), and maternal heart rate (MHR). It is indicated for use on women who are at >36 completed weeks, in labor, with singleton pregnancies. It is intended for use by a healthcare professional in a clinical setting.
Type of Use (Select one or both, as applicable)
XX Prescription Use (Part 21 CFR 801 Subpart D)
] Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Page 1 of 2
PSC Publishing Services (301) 443-
3
510(k) Summary Page 1 of 7 12-Jan-15
Date Prepared:
OBMedical Company 107 SW 140th Terrace, Suite 1 Newberry, FL 32669 Tel - 352.225.3682
| Official Contact: | Suha Jhaveri, COO |
|---|---|
| Proprietary or Trade Name: | LaborView LV1000 |
| Common/Usual Name: | External uterine contraction monitor |
| Classification Name: | OSP - uterine electromyographic monitor (CFR 884.2720) |
| HGM - Perinatal monitoring system (CFR 884.2740) | |
| Predicate Devices: | K112390 - Monica Healthcare - AN24 |
Device Description:
The LaborView LV1000 is a uterine activity and maternal and fetal heart rate sensor replacement intended to interface to existing perinatal monitors in use in hospital delivery environments.
LaborView is comprised of an electrode array, a wireless front-end ("Front-end"), computational back-end ("Back-end"), a power supply module, and optional adapters to connect to various perinatal monitors. The electrode array is sensitive to changes in electrical characteristics of the skin due to muscle contractions, maternal, and fetal ECG when placed on the expectant mother's abdomen. These signals are passed to LaborView, converted to a contraction curve and maternal heart rate (MHR), and fetal heart rate (FHR), and subsequently passed to the perinatal monitor. Note not all perinatal monitors support input of the MHR.
Labor View includes the hardware and firmware necessary to convert the electrical signals obtained via the electrode array into contraction, MHR, and FHR curves.
Labor View provides analog interfaces to the electrode array and the perinatal monitor but may also interface via USB to a data collection application running on a host PC.
The Front-end mates to the electrode array, digitizes the signals and transmits the signals wirelessly to the Back-end component. The Back-end receives the signals from the Front-end. implements the digital signal processing to create the MHR, FHR and contraction curves, then transmits them via the monitor cable/interface to the existing perinatal monitor.
A variety of connector adapters may exist between the Back-end and the perinatal monitor such that a single Back-end design can interface to a variety of perinatal monitor manufacturers and models.
The LaborView system power is supplied via an isolated power supply or a rechargeable battery pack.
4
510(k) Summary Page 2 of 7 12-Jan-15
All of the components of Labor View work together with the perinatal monitor to complete a system that can detect maternal contractions, MHR and FHR during labor. The perinatal monitor, in turn, may interface to a central monitoring system in order to conveniently present contraction information to clinicians.
Indications for Use:
Labor View LV1000 Wireless Electrode System is a transabdominal electromyography and electrocardiography intrapartum maternal-fetal sensor. It works non-invasively via surface electrodes on the maternal abdomen with appropriate monitors to measure fetal heart rate (FHR), uterine activity (UA), and maternal heart rate (MHR). It is indicated for use on women who are at >36 completed weeks, in labor, with singleton pregnancies. It is intended for use by a healthcare professional in a clinical setting.
Patient Population:
Women (>36 completed weeks of gestation) in labor, with singleton pregnancies.
Contraindications:
LaborView is contraindicated for use in preterm gestation (36 completed weeks, in labor, with
singleton pregnancies. It is intended for use by a healthcare
professional in a clinical setting. |
| Patient population | It is intended for use on women who are at term (>36
completed weeks), in labor, with singleton pregnancies, using
surface electrodes on the maternal abdomen | It is intended for use on women who are at term (>36
completed weeks), in labor, with singleton pregnancies, using
surface electrodes on the maternal abdomen |
| Prescriptive | Trained medical personnel | Trained medical personnel |
| Environments of use | Clinical settings | Clinical settings |
| Data collected from
sensor array | Uterine Activity (UA)
Fetal Heart rate (FHR)
Maternal Heart rate (MHR) | Uterine Activity (UA)
Fetal Heart rate (FHR)
Maternal Heart rate (MHR) |
| Components of the
"system" | Electrodes placed on abdomen
Cable
Monitor to process and display data | Electrodes placed on abdomen (an array)
Front-end wirelessly transmit data to receiver
Back-end receiver connects to cleared perinatal monitor
Monitor to process and display data*
- The LaborView does not include the perinatal monitor |
| Technology
employed | Transabdominal electromyography and electrocardiography
signals | Transabdominal electromyography and electrocardiography
signals |
| Information
displayed | On graphical monitor | On graphical monitor*
*Labor View is utilizing the existing monitor to display the
information |
6
510(k) Summary
| Predicate | Proposed device | |
|---|---|---|
| Monica AN24 (K112390) | LaborView LV1000 | |
| Patient interface | Surface electrodes - Single patient use, disposable | Surface electrodes (array) - Single patient use, disposable |
| Contraindications | Contraindicated for use in preterm gestation (36 completed weeks), in labor, with ● singleton pregnancies, using surface electrodes on the maternal abdomen |
- . Discussion - The patient population is identical to the predicate - K112390 - Monica AN24.
Environment of Use -
- For use in clinical settings by trained medical personnel ●
- Discussion - The environments of use and personal are identical to the predicate K112390 - Monica AN24.
Technology -
- The use of transabdominal electromyography (EMG) signals to sense uterine activity, ● fetal heart rate, and maternal heart rate via an array of surface electrodes placed on the maternal abdomen.
- . The Labor View is only a sensor that sensing and transmits the signals to a standard perinatal monitor. It utilizes the existing GE Corometrics perinatal monitors for display and alarm functionality.
- Discussion - This technology is identical to the predicate K112390 - Monica AN24. The difference is that the LaborView is connected to a standard perinatal monitor that displays the data and has alarms. The Labor View is replacing or supplementing ultrasound for FHR; pulse oximeter for MHR; and Toco for uterine activity (UA). The Labor View plus an existing perinatal monitor create a total system equivalent to the predicate. This configuration has been demonstrated to be substantially equivalent and any difference does not raise any new safety risks that could not be confirmed through verification and validation testing.
Non-clinical Testing Summary -
We have performed a number of tests appropriate for the proposed device. These tests include:
8
510(k) Summary Page 6 of 7 12-Jan-15
Biocompatibility of Materials -
- . The only materials in contact with the patient are the electrodes. We have performed ISO 10993-1 testing as Surface Contact, Skin, Limited duration of use: cytotoxicity, sensitization, and irritation.
- Discussion The materials have been found to be non-reactive per ISO 10993-1 testing. ●
Electrical, EMC, EMI testing -
- We have evaluated the proposed device per ANSI/AAMI/ES 60601-1 and IEC 60601-1-. 2, and Wireless Coexistence and the device performed as intended meeting the requirements.
- . Discussion - The proposed device met the requirements of the standards and is considered safe.
Bench testing -
- Bench testing was performed to verify the performance to specifications of the proposed . device. In addition, Labor View was tested to ANSI/AAMI EC13 for verification for Maternal Heart Rate (MHR).
- . Discussion - The proposed device was tested to assure that it meets its performance specifications. Upon completion of the tests, it was found to meet its performance requirements.
Clinical Testing Summary -
Usability –
We performed a summative usability study with potential users. Participants used the instructions to complete a series of tasks to evaluate the sensor array placement, device feedback interpretation (i.e., what to do in the case of icons lighting up on the transmitter), and sensor array removal. All participants were able to complete all tasks successfully.
Comparative Clinical Testing -
Measurement of Uterine Activity
A prospective, non-randomized multi-center study enrolling intrapartum patients at term gestation in whom an intrauterine pressure catheter (IUPC) had been placed. Total enrollment was 107 subjects.
The purpose of the study was to evaluate the performance of the Labor View System in a series of term deliveries. The Labor View was compared to standard external sensors [tocodynamometer (Toco) for UA] relative to the gold standard internal sensors [IUPC].
9
510(k) Summary Page 7 of 7 12-Jan-15
Primary Endpoints:
- . For interpretability, a positive percent agreement (PPA) was calculated for each patient. LaborView (or Toco) uterine activity vs. IUPC gold standard was organized into a 2x2 table representing interpretable and uninterpretable data. PPA was defined as the percent of 0.125 second epochs with interpretable IUPC (gold standard data) that are also interpretable by the LaborView or Toco.
- . For sensitivity, the individual contractions identified by LaborView or toco and the IUPC gold standard vs. those detected only by the IUPC was tabulated. The proportion of contractions detected within +/- 30 seconds by Labor View or Toco was calculated.
- For timing accuracy, the difference in timing of corresponding contractions between the IUPC gold standard and the LaborView (or Toco) was calculated.
All three of the above endpoints were tested using non-inferiority hypotheses.
The results of the study indicated that the Labor View device performed as well as Toco for measuring uterine activity.
Substantial Equivalence Conclusion:
The sponsor has demonstrated through performance testing, design and features, non-clinical, and clinical testing that the proposed device has been found to substantially equivalent to the predicate device.